WINDTREE THERAPEUTICS INC /DE/ Impairment of Intangible Assets (Excluding Goodwill)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Impairment of Intangible Assets (Excluding Goodwill) of $1.12 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for the quarter ending 2022-12-31 was $6.82M, a 5.28% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for the quarter ending 2022-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for the quarter ending 2021-12-31 was $7.20M.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for fiscal 2024 was $1.12M.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for fiscal 2022 was $6.82M, a 84.85% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ impairment of intangible assets (excluding goodwill) for fiscal 2021 was $45.02M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 3 month as first filed | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $1.12M 10-K · filed 2025-04-15 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-04-15 | ||||
| 2022-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $6.82M derived: sum of 2 quarters · filed 2024-04-16 | $6.82M derived: sum of 3 quarters · filed 2024-04-16 | $6.82M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | $7.20M 10-K · filed 2023-03-31 | $7.20M derived: sum of 2 quarters · filed 2023-03-31 | $45.00M derived: sum of 3 quarters · filed 2023-03-31 | $45.02M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $37.80M derived: sum of 2 quarters · filed 2023-03-31 | $37.77M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $37.80M 10-K · filed 2023-03-31 | $37.77M 10-Q · filed 2021-08-05 | $37.77M 10-Q · filed 2022-08-11 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |